The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Individual NSAIDs and Upper Gastrointestinal Complications: A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)
Open accessAbstract
BACKGROUND: The risk of upper gastrointestinal (GI) complications associated with the use of NSAIDs is a serious public health concern. The risk varies between individual NSAIDs; however, there is little information on the risk associated with some NSAIDs and on the impact of risk factors. These data are necessary to evaluate the benefit-risk of individual NSAIDs for clinical and health policy decision making. Within the European Community's Seventh Framework Programme, the Safety Of non-Steroidal anti-inflammatory drugs (NSAIDs) [SOS] project aims to develop decision models for regulatory and clinical use of individual NSAIDs according to their GI and cardiovascular safety. OBJECTIVE: The aim of this study was to conduct a systematic review and meta-analysis of observational studies to provide summary relative risks (RR) of upper GI complications (UGIC) associated with the use of individual NSAIDs, including selective cyclooxygenase-2 inhibitors. METHODS: We used the MEDLINE database to identify cohort and case-control studies published between 1 January 1980 and 31 May 2011, providing adjusted effect estimates for UGIC comparing individual NSAIDs with non-use of NSAIDs. We estimated pooled RR and 95% CIs of UGIC for individual NSAIDs overall and by dose using fixed- and random-effects methods. Subgroup analyses were conducted to evaluate methodological and clinical heterogeneity between studies. RESULTS: A total of 2984 articles were identified and 59 were selected for data abstraction. After review of the abstracted information, 28 studies met the meta-analysis inclusion criteria. Pooled RR ranged from 1.43 (95% CI 0.65, 3.15) for aceclofenac to 18.45 (95% CI 10.99, 30.97) for azapropazone. RR was less than 2 for aceclofenac, celecoxib (RR 1.45; 95% CI 1.17, 1.81) and ibuprofen (RR 1.84; 95% CI 1.54, 2.20); 2 to less than 4 for rofecoxib (RR 2.32; 95% CI 1.89, 2.86), sulindac (RR 2.89; 95% CI 1.90, 4.42), diclofenac (RR 3.34; 95% CI 2.79, 3.99), meloxicam (RR 3.47; 95% CI 2.19, 5.50), nimesulide (RR 3.83; 95% CI 3.20, 4.60) and ketoprofen (RR 3.92; 95% CI 2.70, 5.69); 4-5 for tenoxicam (RR 4.10; 95% CI 2.16, 7.79), naproxen (RR 4.10; 95% CI 3.22, 5.23), indometacin (RR 4.14; 95% CI 2.91, 5.90) and diflunisal (RR 4.37; 95% CI 1.07, 17.81); and greater than 5 for piroxicam (RR 7.43; 95% CI 5.19, 10.63), ketorolac (RR 11.50; 95% CI 5.56, 23.78) and azapropazone. RRs for the use of high daily doses of NSAIDs versus non-use were 2-3 times higher than those associated with low daily doses. CONCLUSIONS: We confirmed variability in the risk of UGIC among individual NSAIDs as used in clinical practice. Factors influencing findings across studies (e.g. definition and validation of UGIC, exposure assessment, analysis of new vs prevalent users) and the scarce data on the effect of dose and duration of use of NSAIDs and on concurrent use of other medications need to be addressed in future studies, including SOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
(2014) · Medical Entomology and Zoology · Cited by 17,633
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
Langman, M. J. S., Weil, J., Wainwright, P., Lawson, D. H., Rawlins, M. D., Logan, R. F. A., Murphy, M., Vessey, M. P., & Colin-Jones, D. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90185-6 · Cited by 872
Griffin, M. R., Piper, J. M., Daugherty, J. R., Snowden, M., & Ray, W. A. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-4-257 · Cited by 758
Hernández-Díaz, S., & Rodríguez, L. A. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2093 · Cited by 716
McGettigan, P., & Henry, D. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001098 · Cited by 571
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER
Somerville, K., Faulkner, G., & Langman, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92927-2 · Cited by 540
Lanas, A., García-Rodríguez, L. A., Arroyo, M. T., Gomollón, F., Feu, F., González-Pérez, A., Zapata, E., Bástida, G., Rodrigo, L., Santolaria, S., et al. (2006) · Gut · doi:10.1136/gut.2005.080754 · Cited by 524
García Rodríguez, L. A., Cattaruzzi, C., Troncon, M. G., & Agostinis, L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.33 · Cited by 335
Alberto García Rodríguez, L., & Hernández-Díaz, S. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00018 · Cited by 307
MacDonald, T. M., Morant, S. V., Robinson, G. C., Shield, M. J., McGilchrist, M. M., Murray, F. E., & McDevitt, D. G. (1997) · BMJ · doi:10.1136/bmj.315.7119.1333 · Cited by 296
Mamdani, M., Rochon, P. A., Juurlink, D. N., Kopp, A., Anderson, G. M., Naglie, G., Austin, P. C., & Laupacis, A. (2002) · BMJ · doi:10.1136/bmj.325.7365.624 · Cited by 270
Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding
Massó González, E. L., Patrignani, P., Tacconelli, S., & Rodríguez, L. A. G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27412 · Cited by 264
Upper Gastrointestinal Bleeding Associated with the Use of NSAIDs: Newer Versus Older Agents
Laporte, J.-R., Ib????ez, L., Vidal, X., Vendrell, L., & Leone, R. (2004) · Drug Safety · doi:10.2165/00002018-200427060-00005 · Cited by 256
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
Yola, M., & Lucien, A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90170-8 · Cited by 253
García Rodríguez, L. A., & Barreales Tolosa, L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.007 · Cited by 249
Hippisley-Cox, J., Coupland, C., & Logan, R. (2005) · BMJ · doi:10.1136/bmj.331.7528.1310 · Cited by 243
Gutthann, S. P., GarcíaRodríguez, L. A., & Raiford, D. S. (1997) · Epidemiology · doi:10.1097/00001648-199701000-00003 · Cited by 225
The Relative Gastrointestinal Toxicity of the Nonsteroidal Anti-inflammatory Drugs
Carson, J. L. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.6.1054 · Cited by 220
Suissa, S., & Garbe, E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0652 · Cited by 179
ADAPT Research Group (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010033 · Cited by 176
Battistella, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.189 · Cited by 162
Sakamoto, C., Sugano, K., Ota, S., Sakaki, N., Takahashi, S., Yoshida, Y., Tsukui, T., Osawa, H., Sakurai, Y., Yoshino, J., et al. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0171-6 · Cited by 143
Self-citationRodriguez, L. A. G. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwh005 · Cited by 137
Upper gastrointestinal bleeding among users of NSAIDs: a population‐based cohort study in Denmark
Mellemkjær, L., Blot, W. J., Sørensen, H. T., Thomassen, L., McLaughlin, J. K., Nielsen, G. L., & Olsen, J. H. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01220.x · Cited by 135
Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy
Savage, R. L., Moller, P. W., Ballantyne, C. L., & Wells, J. E. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360114 · Cited by 126
Raiford, D. S., Perez‐Gutthann, S., & Rodríguez, L. A. G. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00018 · Cited by 125
Self-citationKaufman, D. W., Kelly, J. P., Wiholm, B., et al. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01517.x · Cited by 124
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding
Kaufman, D. W., Kelly, J. P., Sheehan, J. E., László, A., Wiholm, B., Alfredsson, L. S., Koff, R. S., & Shapiro, S. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.55 · Cited by 118
MacDonald, T. M., Morant, S. V., Goldstein, J. L., Burke, T. A., & Pettitt, D. (2003) · Gut · doi:10.1136/gut.52.9.1265 · Cited by 110
Schneeweiß, S., Solomon, D. H., Wang, P. S., Rassen, J. A., & Brookhart, M. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22219 · Cited by 102
Rahme, E., & Nedjar, H. (2007) · Rheumatology · doi:10.1093/rheumatology/kel428 · Cited by 92
Stroke risk and NSAIDs: a systematic review of observational studies
Varas‐Lorenzo, C., Riera‐Guàrdia, N., Calingaert, B., Castellsagué, J., Pariente, A., Scotti, L., Sturkenboom, M., & Perez‐Gutthann, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2227 · Cited by 92
Self-citationRodríguez, L. A. G., Walker, A. M., & Perez‐Gutthann, S. (1992) · Epidemiology · doi:10.1097/00001648-199207000-00008 · Cited by 91
Self-citationEpidemiology overview of gastrointestinal and renal toxicity of NSAIDs.
Henry, D. A., & McGettigan, P. (2003) · PubMed · Cited by 88
Cattaruzzi, C., Troncon, M. G., Agostinis, L., & Rodríguez, L. A. G. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00004-9 · Cited by 88
Ray, W. A., Chung, C. P., Stein, C., Smalley, W. E., Hall, K., Arbogast, P. G., & Griffin, M. R. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.058 · Cited by 80
Pilotto, A., Franceschi, M., Leandro, G., Paris, F., Niro, V., Longo, M. G., D'Ambrosio, P., Andriulli, A., & Mario, F. D. (2003) · Aging Clinical and Experimental Research · doi:10.1007/bf03327372 · Cited by 76
Lanas, Á., Serrano, P., Bajador, E., Fuentes, J., & Sainz, R. L. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200302000-00011 · Cited by 73
van der Linden, M. W., van der Bij, S., Welsing, P. M. J., Kuipers, E. J., & Herings, R. M. C. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.087254 · Cited by 60
Nørgård, B. M., Pedersen, L. H., Johnsen, S. P., Tarone, R. E., McLaughlin, J. K., Friis, S., & Sørensen, H. T. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01913.x · Cited by 56
Fries, J. F., & Bruce, B. (2003) · PubMed · Cited by 55
Low‐Dose Diclofenac, Naproxen, and Ibuprofen Cohort Study
Perez‐Gutthann, S., García‐Rodríguez, L. A., Oliart, A. D., & Varas‐Lorenzo, C. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.10.854.31550 · Cited by 49
Self-citationChang, C., Chen, H., Lin, J., Kuo, C.-W., Shau, W., & Lai, M. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2140 · Cited by 48
Rahme, E., Bardou, M., Dasgupta, K., Toubouti, Y. M., Ghosn, J., & Barkun, A. N. (2006) · Rheumatology · doi:10.1093/rheumatology/kel223 · Cited by 46
Jick, S. S. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.9.741.35209 · Cited by 42
Nobili, A., Mosconi, P., Franzosi, M. G., & Tognoni, G. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010204 · Cited by 36
Castellsagué, J., Holick, C. N., Hoffman, C., Gimeno, V., Stang, M., & Perez‐Gutthann, S. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.12.1397 · Cited by 33
Self-citationRahme, E., Nedjar, H., BIZZI, A., & Morin, S. N. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03523.x · Cited by 28
Kaplan, R. C., Heckbert, S. R., & Psaty, B. M. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1008 · Cited by 26
Application of a propensity score to adjust for channelling bias with NSAIDs
Morant, S. V., Pettitt, D., MacDonald, T. M., Burke, T. A., & Goldstein, J. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.946 · Cited by 18
Case validation in research using large databases
Rodríguez, L. A. G., & Ruigómez, A. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483472 · Cited by 18
Cited by
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
Sostres, C., Gargallo, C. J., & Lanas, A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4175 · Cited by 406
Non-steroidal anti-inflammatory drugs for chronic low back pain
Enthoven, W. T., Roelofs, P. D., Deyo, R. A., van Tulder, M. W., & Koes, B. W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012087 · Cited by 399
The influence of non-steroidal anti-inflammatory drugs on the gut microbiome
Rogers, M. A. M., & Aronoff, D. M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.003 · Cited by 346
Theken, K. N., Lee, C. R., Gong, L., Caudle, K. E., Formea, C. M., Gaedigk, A., Klein, T. E., Agúndez, J. A. G., & Grosser, T. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1830 · Cited by 351
Acute pain: a multifaceted challenge – the role of nimesulide
Kress, H. G., Baltov, A., Basiński, A., Berghea, F., Castellsague, J., Codreanu, C., Copaciu, E., Giamberardino, M. A., Hakl, M., Hrazdira, L., et al. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1100986 · Cited by 316
Self-citation
Metadata
- Authors
- Castellsague, J., Riera-Guardia, N., Calingaert, B., Varas-Lorenzo, C., Fourrier-Reglat, A., Nicotra, F., Sturkenboom, M., Perez-Gutthann, S., & Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project
- Venue
- Drug Safety
- Published
- 2012-12
- Volume
- 35
- Issue
- 12
- Pages
- 1127-1146
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W1984658180
- Cited by
- 341
- References
- 57
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.